THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,119,691 | +10.7% | 545,427 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,530,630 | +11.9% | 545,427 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,941,569 | -3.0% | 545,427 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $5,096,379 | -13.5% | 533,094 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $5,891,000 | +228.4% | 533,094 | +119.8% | 0.00% | – |
| Q3 2021 | $1,794,000 | -69.9% | 242,494 | -40.9% | 0.00% | -100.0% |
| Q2 2021 | $5,962,000 | -42.7% | 410,611 | -19.5% | 0.00% | -50.0% |
| Q1 2021 | $10,409,000 | -10.9% | 510,011 | -22.5% | 0.00% | -33.3% |
| Q4 2020 | $11,687,000 | -21.7% | 657,681 | -34.9% | 0.00% | -25.0% |
| Q3 2020 | $14,930,000 | -43.4% | 1,009,823 | -19.7% | 0.00% | -50.0% |
| Q2 2020 | $26,382,000 | +8.0% | 1,256,887 | +18.9% | 0.01% | -11.1% |
| Q1 2020 | $24,439,000 | -12.2% | 1,057,513 | -1.7% | 0.01% | +12.5% |
| Q4 2019 | $27,847,000 | +49.6% | 1,075,589 | +12.6% | 0.01% | +33.3% |
| Q3 2019 | $18,614,000 | +22.8% | 955,589 | +2.9% | 0.01% | +20.0% |
| Q2 2019 | $15,159,000 | -23.7% | 928,256 | +5.9% | 0.01% | -16.7% |
| Q1 2019 | $19,863,000 | -11.4% | 876,173 | 0.0% | 0.01% | -25.0% |
| Q4 2018 | $22,422,000 | -18.2% | 876,173 | +4.5% | 0.01% | -11.1% |
| Q3 2018 | $27,402,000 | +51.1% | 838,748 | +4.9% | 0.01% | +50.0% |
| Q2 2018 | $18,132,000 | +4.2% | 799,533 | +11.4% | 0.01% | 0.0% |
| Q1 2018 | $17,405,000 | -19.5% | 717,753 | -7.4% | 0.01% | -25.0% |
| Q4 2017 | $21,610,000 | -21.4% | 774,797 | -3.6% | 0.01% | -20.0% |
| Q3 2017 | $27,506,000 | -14.1% | 803,327 | 0.0% | 0.01% | -23.1% |
| Q2 2017 | $32,005,000 | +8.2% | 803,327 | 0.0% | 0.01% | +8.3% |
| Q1 2017 | $29,578,000 | +7.0% | 803,327 | -7.3% | 0.01% | 0.0% |
| Q4 2016 | $27,631,000 | -7.9% | 866,724 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $30,000,000 | +181.0% | 866,724 | +84.2% | 0.01% | +180.0% |
| Q2 2016 | $10,678,000 | +65.8% | 470,606 | +37.4% | 0.01% | +66.7% |
| Q1 2016 | $6,439,000 | -4.5% | 342,519 | -16.7% | 0.00% | 0.0% |
| Q4 2015 | $6,742,000 | -22.3% | 411,390 | -47.9% | 0.00% | -40.0% |
| Q3 2015 | $8,678,000 | -33.4% | 789,595 | -21.1% | 0.01% | -28.6% |
| Q2 2015 | $13,024,000 | -17.5% | 1,000,256 | +9.9% | 0.01% | -12.5% |
| Q1 2015 | $15,794,000 | +330.9% | 910,276 | +270.6% | 0.01% | +300.0% |
| Q4 2014 | $3,665,000 | -35.3% | 245,617 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $5,662,000 | -63.8% | 245,617 | -50.0% | 0.00% | -25.0% |
| Q2 2014 | $15,662,000 | – | 491,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
| Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
| Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
| Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
| Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
| CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
| Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
| King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
| Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
| PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |